News
3d
InvestorsHub on MSNNovo Nordisk appoints Mike Doustdar as new CEO; Chief Scientific Officer to retireNovo Nordisk (NYSE:NVO) announced on Tuesday that Maziar Mike Doustdar will become its new president and chief executive ...
Founder Jeremy Brown, Ph.D. to continue as Chief Technical Officer, driving scientific vision HALIFAX, NS, July 31, 2025 /CNW/ — Sound Blade Medical, Inc., a leader in handheld histotripsy ...
Dr. Hodous, chief scientific officer, noted, “It has been deeply gratifying to witness the evolution of what began as a formidable scientific challenge—targeting SH2 domains as a therapeutic ...
Roland Kolbeck, Ph.D. Appointed as Chief Scientific Officer - - Joe Monahan, Ph.D. will Continue to Support Aclaris as Special Scientific Advisor to the Chief Executive Officer through March 2026 as ...
Professor Robin May will step down as the FSA’s Chief Scientific Adviser in September to become Interim Chief Scientific ...
Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for ...
CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Jun 9, 2025--Fable Therapeutics Appoints David J. Baker, PhD, as Chief Scientific Officer ...
Investing.com -- Novo Nordisk (NYSE: NVO) has appointed Maziar Mike Doustdar as its new president and chief executive officer, effective August 7, 2025, the company announced on Tuesday.
2d
MyChesCo on MSNAclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific OfficerAclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the appointment of Roland Kolbeck, Ph.D., as its new Chief Scientific ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results